Impetiginized dyshidrotic eczema

5Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

A 16 years old female patient, affected by atopic dermatitis and rhinoconjunctivitis allergica since childhood, requested a dermatologic consultation for lesions which had appeared after 3 months of local treatment with clobethasole propionate. The histological analysis confirmed the diagnosis of dyshidrotic eczema and the microbiological smears demonstrated a significant infection with Staphylococcus aureus. The risk of developing corticosteroids’ side-effects depends on the potency of the product, extended period of use and the volume of product applied. Clobetasol propionate is a group I- highly potent corticosteroid, which should be used for a maximum period of 2 weeks. Several authors have found that this agent has cumulative depot effect, persisting in the epidermis for 4 days after only one application. Taking together these observations, sustained by the clinical case presented above, we can conclude that the infectious risks associated with topical corticosteroid treatment must not be neglected, particularly since treated patients are fragile, and frequently have multiple well-known risk factors.

Cite

CITATION STYLE

APA

Tchernev, G., Zanardelli, M., Voicu, C., Bakardzhiev, I., Lotti, T., Lotti, J., … Wollina, U. (2017). Impetiginized dyshidrotic eczema. Open Access Macedonian Journal of Medical Sciences, 5(4 Special Issue  GlobalDermatology), 539–540. https://doi.org/10.3889/oamjms.2017.081

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free